NCT03765099

Brief Summary

This study will evaluate the effects of animal-assisted interactions (AAI) on stress, anxiety, and quality of life in children with a life-threatening condition and their parents. It is anticipated to be a milestone in understanding the human-animal bond.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 5, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

February 21, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

January 23, 2023

Status Verified

January 1, 2023

Enrollment Period

2.9 years

First QC Date

December 3, 2018

Last Update Submit

January 19, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pediatric Quality of Life

    The Peds Quality of Life measure will be administered to children and their parents (proxy) once a month

    up to 3 months

  • Anxiety

    The state-trait anxiety inventory will be administered to children and their parents after each intervention or usual care visit

    up to 3 months

  • Stress

    Saliva samples to measure cortisol levels will be administered to children after animal-assisted interventions or after completion of measures in usual care group

    up to 3 months

Study Arms (2)

Animal-Assisted Interactions

EXPERIMENTAL

Children and their caregivers randomly assigned to the intervention group will spend approximately 15 min with a registered canine and its owner during potentially anxiety-producing visits to the hospital.

Behavioral: Animal-Assisted Interactions

Usual Care

ACTIVE COMPARATOR

Children and their caregivers randomly assigned to the usual care group will receive usual care which may include play therapy, music therapy or visits with a social worker during their visits to the hospital.

Behavioral: Animal-Assisted Interactions

Interventions

Child and caregivers randomly assigned to the intervention group will spend approximately 15 min with a registered canine and its owner during potentially anxiety-producing visits to the hospital.

Also known as: AAI
Animal-Assisted InteractionsUsual Care

Eligibility Criteria

Age3 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children 3-17 years old
  • Confirmed diagnosis of relapsed or refractory cancer

You may not qualify if:

  • Reported fear or anxiety of dogs (child or parent)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Monroe Carell Jr Children's Hospital at Vanderbilt

Nashville, Tennessee, 37232, United States

Location

Related Publications (2)

  • Mahoney AB, Akard TF, Cowfer BA, Dietrich MS, Newton JL, Gilmer MJ. Impact of Animal-Assisted Interaction on Anxiety in Children With Advanced Cancer and Their Caregivers. J Palliat Med. 2024 Jan;27(1):75-82. doi: 10.1089/jpm.2023.0091. Epub 2023 Sep 25.

  • Cowfer BA, Akard TF, Gilmer MJ. Animal-Assisted Interventions for Children with Advanced Cancer: Child and Parent Perceptions. Palliat Med Rep. 2021 Nov 17;2(1):328-334. doi: 10.1089/pmr.2021.0039. eCollection 2021.

MeSH Terms

Conditions

RecurrenceNeoplasms

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Maryjo Gilmer, PhD

    Vanderbilt Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sponsor Investigator

Study Record Dates

First Submitted

December 3, 2018

First Posted

December 5, 2018

Study Start

February 21, 2019

Primary Completion

December 31, 2021

Study Completion

December 31, 2022

Last Updated

January 23, 2023

Record last verified: 2023-01

Locations